Table 1.

Patient Characteristics

Total	40
Gender
Female	16 (40.0%)
Male	24 (60.0%)
Median age at diagnosis	62.5 (range 16–85)
Alive at study time	1 (2.5%)
Median overall survival	457 days (range 119–1372)
Median progression-free survival	176 days (range 42–835)
Ethnicity
White	28 (70%)
Hispanic	9 (22.5%)
Asian	2 (5%)
Black	1 (2.5%)
Surgery
Biopsy only	2 (5%)
Subtotal resection	33 (82.5%
Total resection	5 (12.5%)
Radiotherapy dose
60 Gy	28 (70%)
40 Gy	12 (30%)
Median FLAIR volumes
PreRT	35.957 cm3 (range 3.150–144.629)
PostRT	29.143 cm3 (range 0.297–175.641)
MGMT status
Methylated	10 (25%)
Unmethylated	16 (40%)
Unknown	14 (35%)
IDH-1 status
Mutated	3 (7.5%)
Unmutated	36 (90%)
Unknown	1 (2.5%)